Progressive multifocal leukoencephalopathy, a review and an extended report of five patients with different immune compromised states
Received 4 February 2008; received in revised form 19 May 2008; accepted 7 July 2008. published online 01 September 2008.
Abstract
Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the brain caused by the JC-virus. Both a decreased cellular or humoral immune response can increase the susceptibility for JC-virus induced PML. Not only HIV infected people are at risk, a wide range of otherwise immune compromised patients are a potential target for this virus. This report of five PML patients shows the importance of a clinician's familiarity with this disease and it's presenting symptoms. The presenting symptoms of PML can sometimes mimic worsening of the underlying disease. Although different therapeutic strategies have been tried, the outcomes remain very poor. In this series, treatment with cidofovir appears not to be effective in treating PML, neither in HIV positive nor HIV negative patients. Experimental therapy with leflunomide, after tapering of the immunosuppressive medication, did change the natural course of PML in one patient.
aErasmus Medical Centre, Department of Intensive Care Medicine, The Netherlands
bErasmus Medical Centre, Department of Internal Medicine and Infectious Diseases, The Netherlands
cErasmus Medical Centre, Department of Internal Medicine and Immunology, The Netherlands
dErasmus Medical Centre, Departments of Internal Medicine and Hospital Pharmacy, The Netherlands
eLeiden University Medical Centre, Department of Medical Microbiology, The Netherlands
fErasmus Medical Centre, Departments of Internal Medicine and Nephrology, The Netherlands
Corresponding author. Erasmus Medical Centre, Department of Intensive Care Medicine, 6 zuid, Postbus 2040, 3000 CA Rotterdam, The Netherlands. Tel.:+31 6 44460607; fax: +31 10 7042874.